DANIELLE CAVIGNAC: Open Payments
NPI 1023515574 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 41 payments from 10 companies in 2025. Trend: 2023 $444 · 2024 $661 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $201 |
| Lilly USA, LLC | 10 | $161 |
| Novo Nordisk Inc | 7 | $135 |
| Exact Sciences Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Amgen Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, Ozempic, MOUNJARO, Cologuard Collection Kit, Kerendia, GEMTESA, KISUNLA, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
